Literature DB >> 8483843

In vivo/in vitro correlation of experimental sustained-release theophylline formulations.

K H Yuen1, A A Desmukh, J M Newton.   

Abstract

A novel multiparticulate sustained-release theophylline formulation, which consisted of spherical drug pellets coated with a rate-controlling membrane, was evaluated in vivo. Two preparations that differ solely in the coat thickness, and hence rate of in vitro drug release, were studied in comparison with a solution of the drug. Both preparations produced serum concentration profiles that are reflective of a slow and sustained rate of absorption. The in vivo release versus time profiles calculated using a deconvolution procedure showed that the two preparations differed in the rate but not the extent of drug release. Satisfactory correlation was also obtained between the in vivo and the in vitro results. When the two preparations were further compared using the parameters, time to reach peak concentration (Tp), peak concentration (Cp), and total area under the serum concentration versus time curves (AUC), a statistically significant difference was observed in the Tp and Cp values but not the AUC values, suggesting that the preparations differed in the rate but not the extent of absorption. In addition, the extent of absorption from both preparations was comparable to that obtained with the drug solution.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483843     DOI: 10.1023/a:1018910421840

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

2.  Evaluation of in vivo drug release by numerical deconvolution using oral solution data as weighting function.

Authors:  K K Chan; F Langenbucher; M Gibaldi
Journal:  J Pharm Sci       Date:  1987-06       Impact factor: 3.534

3.  Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.

Authors:  J Fried; S Zietz
Journal:  Phys Med Biol       Date:  1973-07       Impact factor: 3.609

4.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

5.  Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.

Authors:  G Benedikt; V W Steinijans; R Dietrich
Journal:  Arzneimittelforschung       Date:  1988-08

6.  [Drugs and the organism (V). Biopharmaceutic models and in vivo/in vitro correlation].

Authors:  P Pflegel
Journal:  Pharmazie       Date:  1983-10       Impact factor: 1.267

7.  The relation of product formulation to absorption of oral theophylline.

Authors:  M Weinberger; L Hendeles; L Bighley
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

8.  Assessment of rate and extent of drug absorption.

Authors:  D Cutler
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

9.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

10.  Correlation between in vivo mean dissolution time and in vitro mean dissolution time of ampicillin products.

Authors:  Y Tanigawara; K Yamaoka; T Nakagawa; M Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1982-05
  10 in total
  3 in total

1.  In vitro-in vivo relationship of oral extended-release dosage forms.

Authors:  F Y Liu; N C Sambol; R P Giannini; C Y Liu
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

2.  In vivo/in vitro correlations of nitrofurantoin matrix tablet formulations.

Authors:  H Y Karasulu; G Ertan; T Köse; T Günerí
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jan-Mar       Impact factor: 2.441

3.  Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.

Authors:  N Katori; N Aoyagi; T Terao
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.